New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
21:05 EDTGNOM, ILMNIllumina confirms failed bid for Complete Genomics
Illumina (ILMN) confirmed in a regulatory filing that it is “Party H” as named in the Schedule 14D-9 filed by Complete Genomics (GNOM) in connection with the tender offer by Beta Acquisition Corporation, a wholly owned subsidiary of BGI-Shenzhen, to purchase all of the outstanding common stock of Complete Genomics. Illumina further confirmed that it submitted proposals to acquire Complete Genomics. Illumina’s most recent proposal, submitted on November 5, included the following terms: a per share cash purchase price of $3.30, which represented approximately a 5% premium over the consideration offered by BGI; financed with cash-on-hand; and without any condition for further due diligence. Complete Genomics called Illumina's offer inadequate.
News For ILMN;GNOM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
10:03 EDTILMNIllumina upgraded to Strong Buy from Buy at Tigress Financial
Subscribe for More Information
April 22, 2015
14:11 EDTILMNIllumina falls after results, price target bumps
Subscribe for More Information
13:30 EDTILMNIllumina weakness a buying opportunity, says Cowen
Subscribe for More Information
06:40 EDTILMNIllumina price target raised to $240 from $215 at Citigroup
Subscribe for More Information
06:05 EDTILMNIllumina price target raised to $230 from $220 at Mizuho
Subscribe for More Information
April 21, 2015
19:06 EDTILMNOn The Fly: After Hours Movers
Subscribe for More Information
16:13 EDTILMNIllumina raises FY15 adjusted EPS view to $3.36-$3.42 from $3.12-$3.18
Subscribe for More Information
16:12 EDTILMNIllumina reports Q1 gross margin 69.6% vs. 66.1% in prior year period
Subscribe for More Information
16:11 EDTILMNIllumina reports Q1 adjusted EPS 91c, consensus 72c
Subscribe for More Information
15:28 EDTILMNNotable companies reporting after market close
Subscribe for More Information
April 20, 2015
13:28 EDTILMNIllumina May volatility elevated into Q1 and outlook
Illumina April call option implied volatility is at 89, May is at 48, June is at 34, September at 48; compared to its 26-week average of 37 according to Track Data, suggesting larger near term price movement into the expected release of Q1 results on April 21.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use